CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based production system.
CAP-GT is a regulatory endorsed expression platform for scalable viral vector production. CEVEC has successfully developed CAP-GT suspension cell-derived viral packaging cell lines which enable better scale-up and competitive production costs when compared to adherent cell culture systems. CAP-GT suspension cell lines grow to high cell densities and show a broad viral propagation spectrum. Gene therapy vectors such as lentivirus (LV), adenovirus (AV) and adeno-associated virus (AAV) can be produced at industrial scale.
CAP-Go enables the production of proteins previously out of reach representing a significant proportion of the human proteome that is notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor made glycosylation patterns.
Follow CEVEC on LinkedIn.
Chief Executive Officer
DR. NADINE SANDHÖFER
Director QA and Regulatory Affairs
DR. NICOLE FAUST
Chief Scientific Officer
DR. NICO SCHEER
Chief Business Officer
Cofounder of Forbion Capital Partners
Former Life Science Venture Capitalist
at Creathor Venture
DR. ARISTOTELIS NASTOS
Head of Life Sciences
at NRW Bank Venture Fund
DR. JOACHIM RAUTTER
Partner at PEPPERMINTVENTURE
PARTNERS / Chairman of the Board
DR. KLAUS ZIMMERMANN
Scientific Advisory Board CAP®Go
PROF. DR. JÜRGEN HUBBUCH
Professor at Karlsruhe Institute of Technology
Head of the Institute of Engineering in Life Section IV: Biomolecular Separation Engineering
PROF. DR. THOMAS NOLL
Professor and Chair for Cell Culture Technology
University of Bielefeld
Scientific Advisory Board CAP®GT
PROF. DR. STEFAN KOCHANEK
Professor at the University of Ulm and Director of the Department of Gene Therapy
DR. OTTO MERTEN
Head of Applied Vector Studies